EP2419052A2 - Minimally invasive expandable vertebral implant and method - Google Patents
Minimally invasive expandable vertebral implant and methodInfo
- Publication number
- EP2419052A2 EP2419052A2 EP10714786A EP10714786A EP2419052A2 EP 2419052 A2 EP2419052 A2 EP 2419052A2 EP 10714786 A EP10714786 A EP 10714786A EP 10714786 A EP10714786 A EP 10714786A EP 2419052 A2 EP2419052 A2 EP 2419052A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- membrane
- medical implant
- expandable medical
- rigid component
- laterally rigid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007943 implant Substances 0.000 title claims abstract description 118
- 238000000034 method Methods 0.000 title abstract description 16
- 239000012528 membrane Substances 0.000 claims description 86
- 239000000463 material Substances 0.000 claims description 76
- 239000012530 fluid Substances 0.000 claims description 26
- 210000000988 bone and bone Anatomy 0.000 claims description 9
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 230000002188 osteogenic effect Effects 0.000 claims description 4
- 239000011800 void material Substances 0.000 claims description 4
- 239000002639 bone cement Substances 0.000 claims description 3
- 210000003484 anatomy Anatomy 0.000 abstract description 2
- 238000013459 approach Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 210000004872 soft tissue Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000004927 fusion Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000001537 neural effect Effects 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 230000009969 flowable effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000004705 lumbosacral region Anatomy 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102100033337 PDZ and LIM domain protein 7 Human genes 0.000 description 2
- 101710121660 PDZ and LIM domain protein 7 Proteins 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 2
- 239000003462 bioceramic Substances 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- 229940112869 bone morphogenetic protein Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 238000005056 compaction Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 210000002758 humerus Anatomy 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002684 laminectomy Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007658 neurological function Effects 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- -1 poly ethylenes Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940068921 polyethylenes Drugs 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002320 radius Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000012783 reinforcing fiber Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000000623 ulna Anatomy 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/441—Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4603—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2/4611—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof of spinal prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30721—Accessories
- A61F2/30742—Bellows or hose-like seals; Sealing membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30721—Accessories
- A61F2/30744—End caps, e.g. for closing an endoprosthetic cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/3008—Properties of materials and coating materials radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30579—Special structural features of bone or joint prostheses not otherwise provided for with mechanically expandable devices, e.g. fixation devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
- A61F2002/30583—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with hardenable fluid, e.g. curable in-situ
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
- A61F2002/30588—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with solid particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30589—Sealing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30601—Special structural features of bone or joint prostheses not otherwise provided for telescopic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30604—Special structural features of bone or joint prostheses not otherwise provided for modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30841—Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30904—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves serrated profile, i.e. saw-toothed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0085—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof hardenable in situ, e.g. epoxy resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00017—Iron- or Fe-based alloys, e.g. stainless steel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00029—Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
Definitions
- BACKGROUND It is sometimes necessary to remove one or more vertebrae, or a portion of the vertebrae, from the human spine in response to various pathologies. For example, one or more of the vertebrae may become damaged as a result of tumor growth, or may become damaged by a traumatic or other event. Removal, or excision, of a vertebra may be referred to as a vertebrectomy. Excision of a generally anterior portion, or vertebral body, of the vertebra may be referred to as a corpectomy. An implant is usually placed between the remaining vertebrae to provide structural support for the spine as a part of a corpectomy or vertebrectomy. FIG.
- V 1 illustrates four vertebrae, V 1 -V 4 of a typical lumbar spine and three spinal discs, D 1 -D 3 .
- V 3 is a damaged vertebra and all or a part of V 3 could be removed to help stabilize the spine.
- an implant may be placed between vertebrae V 2 and V 4 .
- the implant inserted between the vertebrae is designed to facilitate fusion between remaining vertebrae.
- the ultimate goal of the procedure is spinal stability, regardless of fusion.
- a successful procedure may decrease pain, preserve or enhance neurological function and allow a patient greater mobility without an external orthosis.
- an implant is designed to replace the function of the excised vertebra and discs.
- All or part of more than one vertebra may be damaged and require removal and replacement in some circumstances. If only a portion of a vertebral body and adjacent discs are removed and replaced, the procedure is called a hemi- vertebrectomy.
- Many implants are known in the art for use in vertebrectomy and corpectomy procedures.
- One class of implants is sized to directly replace the vertebra or vertebrae that are being replaced, without in situ expansion.
- Another class of implants is inserted in a collapsed state and then expanded once properly positioned. Expandable implants may be advantageous because they allow for a smaller incision and entry path when positioning an implant. A smaller incision may be particularly useful with a posterior approach, as illustrated in Fig 2. FIG.
- FIG. 2 is an illustration from the posterior of a portion of a human spine, with one thoracic vertebra removed.
- an implant may be placed through the window W, avoiding the nerve root N.
- the nerve root N may be mobilized to increase the size of the window W slightly, but excess movement may risk damage to the nerve root N. Therefore, for a posterior approach, an initially small expandable implant may have particular utility.
- a posterior approach may be preferred for patients with circumferential tumors or for patients more susceptible to the risks associated with a more extensive anterior approach.
- initially small implants enabling minimal tissue disruption may be useful from any surgical approach to reduce trauma to surrounding tissues and to enhance patient recovery.
- a corpectomy or vertebrectomy implant may be advantageous for a corpectomy or vertebrectomy implant to, as nearly as possible, fill the space vertically between the remaining vertebrae and laterally among the remaining soft tissues. Lateral expansion may increase the contact area between the implant and vertebral endplates. This expansion may reduce the potential for subsidence of the device into the adjacent vertebrae. However, it may be important that the lateral expansion not impinge on the spinal cord or nerve roots. In some instances, it may be useful to control lateral expansion to a particular distance or volume.
- Expandable implants may also be useful in replacing long bones or portions of appendages such as the legs and arms, or a rib or other bone that is generally, though not necessarily, longer than it is wide. Examples include, but are not limited to a femur, tibia, fibula, humerus, radius, ulna, phalanges, clavicle, and any of the ribs. Use of the mechanisms described and claimed herein are equally applicable to treatment or repair of such bones or appendages. Similarly, expandable implants may be useful in at least some spinal fusion procedures where a spinal disc is replaced without replacing a vertebral body.
- the expandable medical implant may include a laterally rigid component and a membrane defining a volume and having an upper surface and an opposite lower surface.
- the membrane may be coupled adjacent to the laterally rigid component.
- the expandable medical implant may also include a port in the expandable medical implant for receiving a fluid that drives or maintains expansion of the expandable medical implant, and a fill material that occupies at least the membrane and provides support between the upper surface and the lower surface.
- the volume defined by the membrane is exclusive of the laterally rigid component.
- An embodiment of the invention is a means for occupying a vertebral space.
- the means may include a linearly expandable means for occupying at least a portion of a space between vertebrae and for providing protection to neural structures, and a laterally expandable means coupled adjacent to the linearly expandable means.
- the laterally expandable means may be for receiving and containing a fill material between the linearly expandable means posteriorly and soft tissues surrounding a spinal column.
- Another embodiment of the invention is a method of occupying a vertebral space.
- the method may include introducing a vertebral prosthesis comprising a laterally rigid expandable component and an adjacent membrane having an upper surface and an opposite lower surface into the vertebral space.
- the method may also include introducing a fluid into the vertebral prosthesis to expand or maintain expansion of the laterally rigid expandable component, and introducing a fill material into the vertebral prosthesis to provide a non-fluidic structural support between the upper surface and the opposite lower surface.
- FIG. 1 is an elevation view of a segment of a lumbar spine.
- FIG. 2 is a posterior perspective view of a portion of a human spine.
- FIG. 3 is a perspective view of an embodiment of an expandable medical implant.
- FIG. 4 is a perspective view of the laterally rigid component embodiment of FIG. 3.
- FIG. 5 is an enlarged perspective view of the implant of FIG. 4.
- FIG. 6 is a plan view of the superior end of the implant of FIG. 3.
- FIG. 7 is a plan view of the inferior end of the implant of FIG. 3.
- FIG. 8 is a plan view of the superior end of the implant of FIG. 4.
- FIG. 9 is a plan view of the superior end of the implant of FIG. 4 with a portion of the end material removed to illustrate the interior or the implant.
- FIG. 10 is a perspective view of an embodiment of an expandable medical implant.
- FIG. 11 is a plan view of the inferior end of the implant of FIG. 10.
- FIG. 12 is a perspective view of an embodiment of an expandable medical implant.
- FIG. 13 is a plan view of the superior end of an embodiment of an expandable medical implant.
- FIG. 14 is a perspective view of an embodiment of an expandable medical implant.
- FIG. 15 is a plan view of the superior end of the implant of FIG. 14.
- FIG. 16 is a perspective view of the expandable medical implant of FIG. 3 in a state prior to expansion.
- FIG. 17 is a perspective view of the laterally rigid component embodiment of FIG. 16.
- FIG. 18 is a perspective view illustrating an embodiment of an expandable medical implant being introduced through a generally posterior approach.
- FIG. 19 is a perspective view illustrating an embodiment of an expandable medical implant expanded between vertebrae.
- FIGS. 3-9 illustrate one embodiment of an expandable medical implant 1 for supporting skeletal structures.
- the expandable medical implant 1 shown includes a laterally rigid component 3 and a membrane 5.
- the illustrated laterally rigid component 3 is a bellows.
- the expandable medical implant 1 will be oriented with the membrane 5 toward the anterior of the spinal column, as noted by the letter A, and with the laterally rigid component 3 toward the posterior of the spinal column, as noted by the letter P.
- the specified orientations are for illustrative purposes only and may be altered in various other embodiments.
- the longitudinal axis, or linear expansion direction L, of the laterally rigid component 3 is also illustrated.
- the laterally rigid component 3 is shown in an expanded state. Expansion of the laterally rigid component 3 may be realized by introduction of a fluid into the laterally rigid component 3, may result from elasticity in the material from which the component is made, from internal or external biasing devices, or from any other effective device for generating expansion.
- the cross-sectional shape of the embodiment of the laterally rigid component 3 is concave-convex.
- the cross-sectional shape of the laterally rigid component 3 may be any functional shape, such as but not limited to, generally round, oval, rectangular, triangular, polygonal, or combinations of these shapes.
- the laterally rigid component 3 illustrated in FIG. 4 is defined herein as "laterally rigid" because it appreciably resists forces applied lateral to its linear axis L.
- Other devices that expand linearly and resist forces applied laterally to their linear axes L, are telescoping devices of FIGS. 10-15.
- any other devices that provide resistance to lateral forces are contemplated in embodiments of the present invention and are within the scope of the claims herein.
- Other devices that may meet these limitations include, but are not limited to, reinforced elastomeric bodies, such as a polymer body impregnated with or in combination with reinforcing fibers, or passively expanding bodies driven by the expansion of other connected components. Resistance to lateral forces may be useful in the illustrated embodiments for protecting posterior neural structures such as, but not limited to, the spinal cord, spinal canal, and nerve roots.
- FIGS. 3-5 illustrate a nozzle 2 extending from the laterally rigid component 3.
- a similar nozzle may, alternatively or in addition, extend from the opposite end of the laterally rigid component 3.
- the illustrated nozzle 2 is open to the interior of the laterally rigid component 3.
- a balloon 11 is shown extending from an open, distal end of the nozzle 2.
- the balloon 11 shown is in fluid communication with the interior of the laterally rigid component 3.
- the nozzle 2 and balloon 11 of some embodiments are configured to extend from the laterally rigid component 3 and into an endplate of an adjacent vertebra.
- the balloon 11 may be filled with a material, such as a flowable material, to assist in attachment of the laterally rigid component 3 to the adjacent vertebra.
- the balloon 11 is filled separately from the laterally rigid component 3 or the membrane 5.
- the balloon 11 may additional have a therapeutic effect on the vertebra.
- the balloon 11, alone or in combination with the nozzle 2 may help to stabilize the vertebra.
- the material used to inflate the balloon 11 may be a curable material or may be a material that is used to expand the balloon 11 , but does not cure in place. Once expanded, the balloon 11 may also receive additional materials that permanently fill the balloon 11 , or that have an additional therapeutic effect on the vertebra. Any of the materials for use in the balloon 11 may also be a fill material 100 as described in detail below.
- the balloon 11 may in whole or in part be non- permeable, semi-permeable, or permeable to allow the flowable material or the fill material 100 to contact the vertebra.
- an end of an embodiment of the laterally rigid component 3 my include teeth, spikes, ridges, indentations, roughening, knurling, or any other device for enhancing fixation between a vertebra and the laterally rigid component 3.
- the embodiments of FIGS. 10-15 illustrate spikes 22 on the end of laterally rigid components.
- the membrane 5 is illustrated in an expanded configuration in FIG. 3.
- the membrane 5 defines a volume and has an upper surface 6 and an opposite lower surface 4.
- the membrane 5 is shown coupled laterally adjacent to the laterally rigid component 3.
- the illustrated membrane 5 and the laterally rigid component 3 are adjacent, with the volume defined by the membrane 5 exclusive of the laterally rigid component 3, as defined herein.
- the membrane 5 of some embodiments is configured to be placed between vertebrae and expanded such that the upper surface 6 contacts a first vertebra and the opposite lower surface 4 contacts a second vertebra to provide support between the vertebrae. Lateral expansion of the membrane 5 is also accomplished in some embodiments. For example, in FIG. 3 anterior expansion, as well as medial-lateral expansion, and intervening radial expansions, are illustrated. As used herein, the term lateral means directions approximately normal to the linear expansion direction L.
- the membrane 5 may be constructed, in whole or in part, of a non-permeable material.
- the membrane 5 may include compliant or non-compliant balloon materials such as those commonly used to manufacture coronary and Kyphoplasty medical devices. Such materials may include, but not be limited to, mylar, rubber, polyurethane, vinyl, latex, poly ethylenes, ionomer, and polytetrapthalate (PET), as well as less flexible materials such as Kevlar®, PEBAX®, stainless steel, titanium, nickel-titanium alloys, and other metals and alloys and/or ceramics.
- a compliant membrane may include reinforcing to limit one or both of the size and shape of the membrane to a clinically advantageous extent.
- a non-compliant membrane may expand more elastically to more completely fill an irregular opening, depending on the amount of material introduced into the membrane.
- the membrane 5 may be constructed, in whole or in part, of a permeable material, which allows a certain amount of fill material 100 to pass through the membrane
- All or a portion may be made permeable by fabricating a material, including but not limited to, the membrane materials listed above, into a fabric, weave, mesh, composite, bonded fiber assembly, or any other manufacture known to those skilled in the art.
- all or part of the upper surface 6 and the opposite lower surface 4 may be constructed of a permeable material to allow fill material 100 to move through the membrane 5 and to come into contact with vertebrae.
- FIGS. 6 and 7 illustrate, respectively, superior and inferior ends of an expanded expandable medical implant 1.
- the laterally rigid component 3 shown includes an upper cap 16 and a lower cap 14.
- the upper and lower caps 16, 14 may be non-permeable or permeable to some degree, with similar functions to, and made from similar materials with, the membrane 5 discussed above.
- the upper and lower caps 16, 14 may be made from the same material as the rest of the laterally rigid component 3, or may be made from a separate material.
- FIG. 8 illustrates an upper cap 16 made from an at least partially permeable woven or mesh material. As illustrated, two mesh ends 17 are integrated into the upper cap 16 to allow passage of some of the fluid or fill material 100 to contact an adjacent vertebra. Alternately, or in addition, the upper cap 16 may be expanded or stretched into contact with an adjacent vertebra to conform to the contours of the vertebral endplate so as to provide an improved interface between the expandable medical implant 1 and the vertebra.
- FIG. 9 shows the upper end cap 16 of FIG. 8 with the two mesh ends 17 removed to illustrate the interior of an embodiment of the laterally rigid component 3.
- the interior shown includes a chamber 13 which is open along the length of the laterally rigid component 3 between the upper and lower caps 16, 14.
- the chamber 13 is open whether the laterally rigid component 3 is in an expanded or unexpanded state.
- the interior edge 15 of the bellows defines an inner periphery of the chamber 13.
- elasticity in the material along the interior edges 15 of the bellows may sever as a biasing force to bias the laterally rigid component 3 toward an expanded or unexpanded state, as may be advantageous in various circumstances. For example, it may be advantageous to bias the laterally rigid component 3 toward an unexpanded state to provide a low profile device for insertion. Other devices may be used to expand the device as needed.
- FIGS. 6 and 7 illustrate the membrane 5 being coupled laterally adjacent to the laterally rigid component 3.
- an adhesive may be applied between the membrane 5 and the laterally rigid component 3 at a first point 18 near the upper surface 6 of the membrane 5.
- the membrane 5 may be coupled to the laterally rigid component 3 with an adhesive applied at a second point 19 near the lower surface 4 of the membrane 5.
- Embodiments of the expandable medical implant 1 also include a port 7 for receiving a fluid.
- a fluid may be a paste, gel, liquid, suspension, granular mixture, or similar substance.
- a substance as described herein will be considered a fluid even if it later cures or hardens to a non-fluidic state.
- the port 7 is connected to the laterally rigid component 3.
- the port 7 may connect to the membrane 5, or to another portion of the expandable medical implant 1.
- the fluid received through the port 7 in some circumstances will drive expansion of the expandable medical implant 1. This may be accomplished by pressurizing the laterally rigid component 3 or the membrane 5, or by pressurizing both.
- the fluid may be used to maintain expansion generated by some other force such as expansion from elasticity in the material from which the laterally rigid component 3 or membrane 5 are made, from biasing devices internal or external to the laterally rigid component 3 or membrane 5, or from any other effective device for generating expansion.
- the illustrated port 7 includes a relief 8 that may be useful in detaching the port 7 from the laterally rigid component 3 after expansion of the implant, but prior to completion of the surgical procedure.
- the relief 8 provides both a tactile indication of an appropriate location to detach the port 7 and a reduced material thickness that allows for less resistance to cutting, breaking, or otherwise removing the port 7.
- the port 7 may also serve as an extension of the expandable medical implant 1 useful in manipulating the expandable medical implant 1 into a clinically effective location.
- a transfer opening 9 is provided between the laterally rigid component 3 and the membrane 5.
- the transfer opening 9 is a hole through which a fluid or fill material 100, or both, may pass. Passage may occur in either direction between the laterally rigid component 3 and the membrane 5 in various embodiments.
- fluid, fill material 100 or both enter the laterally rigid component 3 through the port 7 and pass through the transfer opening 9 into the membrane 5.
- a valve is provided at the transfer opening 9 to control flow between the laterally rigid component 3 and the membrane 5.
- the valve may be controlled by direct manipulation or through instrumentation connected through the port 7.
- the valve may also be pressure actuated such that flow is allowed through the transfer opening 9 above a certain pressure.
- the fill material 100 may enter the expandable medical implant 1 as a fluid, and then harden or cure in the implant.
- a non-hardenable and non- curing fluid is used to expand, or to hold expansion in, the implant or one or some of the components of the implant.
- a fill material 100 may then be introduced into at least the membrane 5 to provide support between the upper surface 6 and the lower surface 4.
- the fill material 100 may be a paste, gel, liquid, suspension, granular mixture, or similar substance.
- Non-limiting examples of fill materials 100 include bone cement, paste, morselized allograft, autograft, or xenograft bone, ceramics, or various polymers.
- An example bone cement is polymethylmethacrylate (PMMA), which may be made from methylmethacrylate, polymethylmethacrylate, esters of methacrylic acid, or copolymers containing polymethylmethacrylate and polystyrene.
- Additional non-limiting examples of the fill material 100 include semi-rigid flowable or hardenable material such as silicone or various types of urethane materials. It should further be understood that other types of fill materials 100 which are not necessarily hardenable or curable may be used in association with the present invention.
- the fill material may comprise beads or small particles or grains of material, some of which may, in aggregate, achieve a harder consistency as a result of interlocking or compaction.
- the fill material may also include a bone growth promoting substance. The use and components of such bone growth promoting substances are described in more detail below.
- FIGS. 10 and 11 show another embodiment of an expandable medical implant 21.
- An inferior side of the implant is illustrated in FIG. 11, as well as in FIG. 10.
- the expandable medical implant 21 shown includes a laterally rigid component 23 and a membrane 25.
- the illustrated laterally rigid component 23 is a telescoping body with spikes 22 for enhanced connection to an adjacent vertebral body.
- the expandable medical implant 21 will be oriented with the membrane 25 toward the anterior of the spinal column and with the laterally rigid component 23 toward the posterior of the spinal column.
- the specified orientations are for illustrative purposes only and may be altered in various other embodiments.
- the laterally rigid component 23 is shown in an expanded state.
- Expansion of the laterally rigid component 23 may be realized by introduction of a fluid into the laterally rigid component 23, may result from a biasing device resident in the laterally rigid component 23, or from any other effective device for generating expansion.
- the membrane 25 is essentially similar to the membrane 5 described in greater detail above.
- a port 27 coupled to the laterally rigid component 23 is also illustrated.
- a relief 28 is depicted that provides both a tactile indication of an appropriate location to detach the port 27 and a reduced material thickness that allows for less resistance to cutting, breaking, or otherwise removing the port 27.
- an adhesive may be applied between the membrane 25 and the laterally rigid component 23.
- FIGS. 10 and 11 illustrate an embodiment where the adhesive may be applied at a point 29 near a lower surface 24 of the membrane 25.
- FIG. 12 illustrates an embodiment of an expandable medical implant 31 with a membrane 35 coupled to a laterally rigid component 33 by a number of tethers 39.
- Each tether 39 may be made of any biocompatible material.
- the tethers 39 illustrated are strands, but in other embodiments may be loops, hooks, staples, fasteners of any kind, or any other component capable of connecting the membrane 35 with the laterally rigid component 33.
- the operation and structures of the embodiment of FIG. 12 are otherwise essentially similar to the operation and structures of the other similar embodiments described herein.
- FIG. 13 illustrates an embodiment of an expandable medical implant 41 with a membrane 45 coupled to a laterally rigid component 43 such that a void 46 is created between the membrane 45 and the laterally rigid component 43.
- the membrane 45 may be coupled to the laterally rigid component 43 by any effective mechanism, including but not limited to an adhesive or tether.
- the void 46 may be filled with an osteogenic material or therapeutic composition. Filling may occur through an opening into the void 46 through the membrane 45, the laterally rigid component 43, or otherwise. Filling may be through a syringe or similar device, through direct placement, or by any other effective mechanism.
- Osteogenic materials include, without limitation, autograft, allograft, xenograft, demineralized bone, synthetic and natural bone graft substitutes, such as bioceramics and polymers, and osteoinductive factors.
- a separate carrier to hold materials within the device may also be used. These carriers may include collagen-based carriers, bioceramic materials, such as BIOGLASS®, hydroxyapatite and calcium phosphate compositions.
- the carrier material may be provided in the form of a sponge, a block, folded sheet, putty, paste, graft material or other suitable form.
- the osteogenic compositions may include an effective amount of a bone morphogenetic protein (BMP), transforming growth factor ⁇ l, insulin- like growth factor, platelet-derived growth factor, fibroblast growth factor, LIM mineralization protein (LMP), and combinations thereof or other therapeutic or infection resistant agents, separately or held within a suitable carrier material.
- BMP bone morphogenetic protein
- transforming growth factor ⁇ l insulin- like growth factor
- platelet-derived growth factor fibroblast growth factor
- LIM mineralization protein LIM mineralization protein
- FIGS. 14 and 15 illustrate an embodiment of an expandable medical implant 51 with a membrane 55 coupled to a laterally rigid component 53.
- the operation and structures of the embodiment of FIGS. 14 and 15 are essentially similar to the operation and structures of the other similar embodiments described herein, except that the membrane 55 is sized or otherwise constrained such that it will only fill one lateral side of a vertebral space into which it is placed.
- the contralateral side of such a vertebral space may be left open for an additional implant, or may include healthy bone material and not need to be excised or filled.
- the membrane 55 may include layers, internal fibers or structures, or non-expandable materials that limit its expansion to one or both of a specific size and shape.
- the size or shape of the membrane 55 may be limited to only fill any particular portion of a vertebral space, not necessarily just a lateral portion.
- FIGS. 16 and 17 show the expandable medical implant 1 of FIG. 3 in an unexpanded or contracted state. Both the laterally rigid component 3 and the membrane 5 are unexpanded linearly. The membrane 5 is unexpanded laterally as well as linearly.
- the port 7 may be used to handle the expandable medical implant 1 or to guide the implant into a position where it can be effectively deployed.
- One manipulation of an embodiment of the expandable medical implant 1 is illustrated in FIGS. 18 and 19.
- Each of the embodiments disclosed herein may be described as a means for occupying a vertebral space. This may be accomplished with a linearly expandable means for occupying at least a portion of a space between vertebrae and for providing protection to neural structures in combination with a laterally expandable means coupled adjacent to the linearly expandable means.
- the laterally expandable means of some embodiments is for receiving and containing a fill material between the linearly expandable means posteriorly and soft tissues surrounding a spinal column.
- the soft tissues surrounding the spinal column may include, but are not limited to, one or more of ligaments, muscles, vessels, arteries, and neural structures.
- Embodiments of the implant in whole or in part may be constructed of biocompatible materials of various types.
- implant materials include, but are not limited to, non-reinforced polymers, carbon-reinforced polymer composites, PEEK and PEEK composites, low density polyethylene, shape-memory alloys, titanium, titanium alloys, cobalt chrome alloys, stainless steel, ceramics and combinations thereof.
- a trial instrument or implant is made from radiolucent material, radiographic markers can be located on the trial instrument or implant to provide the ability to monitor and determine radiographically or fluoroscopically the location of the body in the spinal space.
- the implant or individual components of the implant may be constructed of solid sections of bone or other tissues.
- Tissue materials include, but are not limited to, synthetic or natural autograft, allograft or xenograft, and may be resorbable or non- resorbable in nature.
- tissue materials include, but are not limited to, hard tissues, connective tissues, demineralized bone matrix and combinations thereof.
- FIG. 1 illustrates four vertebrae, Vi-V 4 , of a typical lumbar spine and three spinal discs, D 1 -D 3
- FIG. 2 depicts a portion of a typical thoracic spine.
- Embodiments of the invention may be applied to the lumbar spinal region, and embodiments may also be applied to the cervical or thoracic spine or between other skeletal structures.
- Some embodiments may also include supplemental fixation devices in addition to or as part of the expandable medical implant for further stabilizing the anatomy.
- supplemental fixation devices for example, and without limitation, rod and screw fixation systems, anterior, posterior, or lateral plating systems, facet stabilization systems, spinal process stabilization systems, and any devices that supplement stabilization may be used as a part of or in combination with the expandable medical implant.
- Embodiments of the invention may be useful in at least some spinal fusion procedures where a spinal disc is replaced without replacing a vertebral body.
- FIGS. 18 and 19 illustrate the introduction and expansion of an expandable medical implant into a vertebral space. The implant is placed through the window W, as described above, and past a nerve root N. The window W is created among the soft tissues of a segment of the spinal column.
- the expandable medical implant introduced is a vertebral prosthesis that includes the laterally rigid expandable component 3 and the adjacent membrane 5 with an upper surface and an opposite lower surface.
- FIG. 18 shows a distal end of the expandable medical implant being introduced through the window W first. In other embodiments, another portion of the expandable medical implant may be introduced first and other translational and rotational manipulations may be conducted on the implant as it is introduced.
- the expandable medical implant Once the expandable medical implant has been introduced through the window W and positioned appropriately in the vertebral space, it may be expanded linearly and laterally. A linearly and laterally expanded implant is illustrated in FIG. 19. The embodiment illustrated may be expanded by introducing a fluid through the port 7 and into the laterally rigid component 3.
- Introducing fluid through the port 7 may be caused by pressure or force generated by a syringe, injector, multi-stage injector, central pressurization reservoir, or any effective system or device.
- the fluid introduced to expand the laterally rigid component 3 may be fluid that is introduced only to expand the component, or in some instances, is a final fill material 100.
- the fluid introduce to expand the implant is not, or is not a component of, the fill material 100, the fluid may be removed from the implant after the fill material 100 has been introduced.
- the introduced fluid may be one part of a multi-part fill material.
- the fluid or a fill material 100 may further be passed from the laterally rigid component 3 into the membrane 5 to linearly and laterally expand the membrane 5.
- flow into the laterally rigid component 3 and the membrane 5 are separately controlled so that one or the other may be selectively filled independent from the other.
- an additional port, or a port replacing the port 7 in the laterally rigid component 3 may connect with the membrane 5 directly.
- introduction of the fill material 100 by whatever mechanism that is effective, results in a non-fluidic structural support between the upper and lower surfaces of the membrane 5. Even though a fill material 100 may be initially introduced as a fluid, embodiments of the invention provide for the fill material 100 to cure or harden as noted above and provide structural support. Other fill materials 100 may have a non-fluidic state as a result of interlocking of the particles with one another or with the membrane 5, or may be non-fluidic as a response to compaction.
- the expandable medical implant is shown in FIGS. 18 and 19 as being implanted from a generally posterior approach.
- embodiments of the invention may include implantation from any surgical approach, including but not limited to, posterior, lateral, anterior, transpedicular, lateral extracavitary, in conjunction with a laminectomy, in conjunction with a costotransversectomy, or by any combination of these and other approaches.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/424,941 US20100268341A1 (en) | 2009-04-16 | 2009-04-16 | Minimally invasive expandable vertebral implant and method |
PCT/US2010/031077 WO2010120915A2 (en) | 2009-04-16 | 2010-04-14 | Minimally invasive expandable vertebral implant and method |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2419052A2 true EP2419052A2 (en) | 2012-02-22 |
EP2419052B1 EP2419052B1 (en) | 2014-07-09 |
Family
ID=42810852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10714786.0A Active EP2419052B1 (en) | 2009-04-16 | 2010-04-14 | Minimally invasive expandable vertebral implant |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100268341A1 (en) |
EP (1) | EP2419052B1 (en) |
JP (1) | JP2012523921A (en) |
CN (1) | CN102395333A (en) |
AU (1) | AU2010236483A1 (en) |
WO (1) | WO2010120915A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100204794A1 (en) * | 2007-06-06 | 2010-08-12 | Peter Jarzem | Prosthetic vertebral body |
US7976578B2 (en) * | 2008-06-04 | 2011-07-12 | James Marvel | Buffer for a human joint and method of arthroscopically inserting |
US20120109304A1 (en) * | 2010-10-29 | 2012-05-03 | Warsaw Orthopedic, Inc. | Medical implant and method for photodynamic therapy |
US8394129B2 (en) | 2011-03-10 | 2013-03-12 | Interventional Spine, Inc. | Method and apparatus for minimally invasive insertion of intervertebral implants |
US8518087B2 (en) | 2011-03-10 | 2013-08-27 | Interventional Spine, Inc. | Method and apparatus for minimally invasive insertion of intervertebral implants |
US8685096B2 (en) | 2011-08-23 | 2014-04-01 | Amendia, Inc. | Lumbar fusion device |
US9585764B2 (en) * | 2012-07-26 | 2017-03-07 | Warsaw Orthopedic, Inc. | Bone implant device |
US20140067069A1 (en) | 2012-08-30 | 2014-03-06 | Interventional Spine, Inc. | Artificial disc |
US9277928B2 (en) | 2013-03-11 | 2016-03-08 | Interventional Spine, Inc. | Method and apparatus for minimally invasive insertion of intervertebral implants |
US9993353B2 (en) | 2013-03-14 | 2018-06-12 | DePuy Synthes Products, Inc. | Method and apparatus for minimally invasive insertion of intervertebral implants |
US9968460B2 (en) | 2013-03-15 | 2018-05-15 | Medsmart Innovation Inc. | Dynamic spinal segment replacement |
DE102013113168A1 (en) | 2013-11-28 | 2015-06-11 | Humantech Germany Gmbh | Vertebral body replacement implant with worm gear |
US10350082B2 (en) * | 2015-10-26 | 2019-07-16 | Tobb Ekonomi Ve Teknoloji Universitesi | Expandable cage |
DE202016001980U1 (en) | 2016-03-24 | 2016-04-25 | Humantech Germany Gmbh | Lumbar vertebral body replacement implant, characterized in that it comprises a spreading device for applying an expanding force (F), a gear and a drive axle |
CN106264794B (en) * | 2016-07-31 | 2023-10-03 | 上海市肺科医院 | Combined prosthesis for sternal reconstruction |
CN114652490B (en) * | 2022-05-20 | 2022-09-02 | 茂名市人民医院 | Foldable artificial meniscus |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA992255A (en) * | 1971-01-25 | 1976-07-06 | Cutter Laboratories | Prosthesis for spinal repair |
US4554914A (en) * | 1983-10-04 | 1985-11-26 | Kapp John P | Prosthetic vertebral body |
DE8807485U1 (en) * | 1988-06-06 | 1989-08-10 | Mecron Medizinische Produkte Gmbh, 1000 Berlin | Intervertebral disc endoprosthesis |
US4932975A (en) * | 1989-10-16 | 1990-06-12 | Vanderbilt University | Vertebral prosthesis |
US5236460A (en) * | 1990-02-12 | 1993-08-17 | Midas Rex Pneumatic Tools, Inc. | Vertebral body prosthesis |
US5290312A (en) * | 1991-09-03 | 1994-03-01 | Alphatec | Artificial vertebral body |
EP0555807B1 (en) * | 1992-02-10 | 1996-08-21 | Matsumoto Dental College | Bone substitute product and method of producing the same |
US5336223A (en) * | 1993-02-04 | 1994-08-09 | Rogers Charles L | Telescoping spinal fixator |
DE4417629B4 (en) * | 1993-06-24 | 2006-03-16 | SDGI Holdings, Inc., Wilmington | Implant for the replacement of vertebral bodies |
US7201774B2 (en) * | 1999-10-08 | 2007-04-10 | Ferree Bret A | Artificial intervertebral disc replacements incorporating reinforced wall sections |
US6592625B2 (en) * | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
WO2001028464A1 (en) * | 1999-10-20 | 2001-04-26 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US7717958B2 (en) * | 2000-02-16 | 2010-05-18 | Trans1, Inc. | Prosthetic nucleus apparatus |
US20030028251A1 (en) * | 2001-07-30 | 2003-02-06 | Mathews Hallett H. | Methods and devices for interbody spinal stabilization |
US6375682B1 (en) * | 2001-08-06 | 2002-04-23 | Lewis W. Fleischmann | Collapsible, rotatable and expandable spinal hydraulic prosthetic device |
US20030083749A1 (en) * | 2001-10-31 | 2003-05-01 | Kuslich Stephen D. | Corpectomy device |
ATE395885T1 (en) * | 2002-11-21 | 2008-06-15 | Warsaw Orthopedic Inc | SYSTEM FOR INTERVERTEBRAL STABILIZATION USING EXPANDABLE DEVICES |
US7563281B2 (en) * | 2003-04-03 | 2009-07-21 | Warsaw Orthopedic, Inc. | Apparatus and method for supporting vertebral bodies |
US6984246B2 (en) * | 2003-06-06 | 2006-01-10 | Tain-Yew Shi | Artificial intervertebral disc flexibly oriented by spring-reinforced bellows |
CA2588388A1 (en) * | 2004-12-01 | 2006-06-08 | The Regents Of The University Of California | Systems, devices and methods of treatment of intervertebral disorders |
CA2598742A1 (en) * | 2005-03-01 | 2006-09-08 | Columna Pty Ltd | Intervertebral disc restoration |
US7628800B2 (en) * | 2005-06-03 | 2009-12-08 | Warsaw Orthopedic, Inc. | Formed in place corpectomy device |
US7985256B2 (en) * | 2005-09-26 | 2011-07-26 | Coalign Innovations, Inc. | Selectively expanding spine cage, hydraulically controllable in three dimensions for enhanced spinal fusion |
US8070813B2 (en) * | 2005-09-26 | 2011-12-06 | Coalign Innovations, Inc. | Selectively expanding spine cage, hydraulically controllable in three dimensions for vertebral body replacement |
US7799079B2 (en) * | 2006-01-18 | 2010-09-21 | Zimmer Spine, Inc. | Vertebral fusion device and method |
US20070260315A1 (en) * | 2006-05-03 | 2007-11-08 | Foley Kevin T | Devices and methods for disc height restoration |
US8062337B2 (en) * | 2006-05-04 | 2011-11-22 | Warsaw Orthopedic, Inc. | Expandable device for insertion between anatomical structures and a procedure utilizing same |
US7731752B2 (en) * | 2006-07-21 | 2010-06-08 | Warsaw Orthopedic, Inc. | Implant with nested members and methods of use |
US20080058931A1 (en) * | 2006-07-21 | 2008-03-06 | John White | Expandable vertebral implant and methods of use |
US20080021556A1 (en) * | 2006-07-21 | 2008-01-24 | Edie Jason A | Expandable vertebral implant and methods of use |
US7875079B2 (en) * | 2006-12-14 | 2011-01-25 | Warsaw Orthopedic, Inc. | Vertebral implant containment device and methods of use |
US8187328B2 (en) * | 2007-01-08 | 2012-05-29 | Warsaw Orthopedic, Inc. | Expandable containment devices and methods |
US8273124B2 (en) * | 2007-05-17 | 2012-09-25 | Depuy Spine, Inc. | Self-distracting cage |
US20100204794A1 (en) * | 2007-06-06 | 2010-08-12 | Peter Jarzem | Prosthetic vertebral body |
US20100268340A1 (en) * | 2009-04-16 | 2010-10-21 | Warsaw Orthopedic, Inc. | Minimally Invasive Expandable Contained Vertebral Implant and Method |
-
2009
- 2009-04-16 US US12/424,941 patent/US20100268341A1/en not_active Abandoned
-
2010
- 2010-04-14 WO PCT/US2010/031077 patent/WO2010120915A2/en active Application Filing
- 2010-04-14 AU AU2010236483A patent/AU2010236483A1/en not_active Abandoned
- 2010-04-14 CN CN2010800178396A patent/CN102395333A/en active Pending
- 2010-04-14 EP EP10714786.0A patent/EP2419052B1/en active Active
- 2010-04-14 JP JP2012506173A patent/JP2012523921A/en active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO2010120915A2 * |
Also Published As
Publication number | Publication date |
---|---|
CN102395333A (en) | 2012-03-28 |
EP2419052B1 (en) | 2014-07-09 |
AU2010236483A1 (en) | 2011-10-27 |
US20100268341A1 (en) | 2010-10-21 |
WO2010120915A3 (en) | 2011-01-20 |
WO2010120915A2 (en) | 2010-10-21 |
JP2012523921A (en) | 2012-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2419052B1 (en) | Minimally invasive expandable vertebral implant | |
EP2419937B1 (en) | Minimally invasive expandable contained vertebral implant | |
US8123809B2 (en) | Deployment system and method for an expandable vertebral implant | |
US8123808B2 (en) | Vertebral endplate connection implant and method | |
EP2142147B1 (en) | Selectively expanding spine cage, hydraulically controllable in three dimensions for vertebral body replacement | |
JP5876465B2 (en) | Interosseous device | |
US20110218627A1 (en) | System and method for replacing at least a portion of a vertebral body | |
JP2006510400A (en) | Systems and techniques for spinal stabilization between vertebral bodies using expandable devices | |
JP2010510026A (en) | Method and apparatus for minimally invasive modular interbody fusion device | |
EP2967695B1 (en) | Adjustable multi-volume balloon for spinal interventions | |
US7918889B2 (en) | Expandable spinal prosthetic devices and associated methods | |
US8673007B2 (en) | Implant with insertion device and method | |
US8353957B2 (en) | Expandable medical device and method | |
AU2014201372B2 (en) | Selectively expanding spine cage with enhanced bone graft infusion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20111004 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20140129 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 676288 Country of ref document: AT Kind code of ref document: T Effective date: 20140715 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602010017340 Country of ref document: DE Effective date: 20140821 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 676288 Country of ref document: AT Kind code of ref document: T Effective date: 20140709 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140709 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141009 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141110 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141009 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141010 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141109 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602010017340 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20150410 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150414 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20150414 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150414 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150430 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20100414 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240320 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240320 Year of fee payment: 15 |